KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Unitedhealth (UNH) EBIT (2016 - 2025)

Unitedhealth (UNH) has disclosed EBIT for 17 consecutive years, with $380.0 million as the latest value for Q4 2025.

  • On a quarterly basis, EBIT fell 95.11% to $380.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $19.0 billion, a 41.26% decrease, with the full-year FY2025 number at $19.0 billion, down 41.26% from a year prior.
  • EBIT was $380.0 million for Q4 2025 at Unitedhealth, down from $4.3 billion in the prior quarter.
  • In the past five years, EBIT ranged from a high of $9.1 billion in Q1 2025 to a low of $380.0 million in Q4 2025.
  • A 5-year average of $6.8 billion and a median of $7.3 billion in 2022 define the central range for EBIT.
  • Peak YoY movement for EBIT: skyrocketed 57.55% in 2021, then tumbled 95.11% in 2025.
  • Unitedhealth's EBIT stood at $5.5 billion in 2021, then increased by 24.36% to $6.9 billion in 2022, then rose by 11.58% to $7.7 billion in 2023, then grew by 1.09% to $7.8 billion in 2024, then crashed by 95.11% to $380.0 million in 2025.
  • Per Business Quant, the three most recent readings for UNH's EBIT are $380.0 million (Q4 2025), $4.3 billion (Q3 2025), and $5.2 billion (Q2 2025).